Coronavirus vaccine developer CureVac raises $213 million in IPO – source

16Views

August 14, 2020

CureVac BV raised $213 million in its initial public offering on Thursday, a person familiar with the matter said, setting the stage for the first stock market debut of a company developing a promising vaccine to combat the novel coronavirus.

Reuters

Last Updated: August 14, 2020, 7:10 AM IST

NEW YORK CureVac BV raised $213 million in its initial public offering on Thursday, a person familiar with the matter said, setting the stage for the first stock market debut of a company developing a promising vaccine to combat the novel coronavirus.

The German biotechnology firm sold 13.33 million shares at $16 apiece, the top end of its indicated price range, the source said, requesting anonymity ahead of an initial announcement. The company’s shares are set to trade in New York on Friday.

CureVac did not immediately respond to a request for comment.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Array
(
[videos] => Array
(
[0] => Array
(
[id] => 5f357190a07a3a25bbc1b0b5
[youtube_id] => gryv85YLKx8
Coronavirus vaccine developer CureVac raises $213 million in IPO – source => B’luru Riots: BJP MP Tejasvi Surya Says ‘Mob Came Prepared For A Riot’ | Brass Tacks | CNN News18
)

[1] => Array
(
[id] => 5f3571d0a28c9c25c1c3a9a0
[youtube_id] => LEaGa_r0MHE
Coronavirus vaccine developer CureVac raises $213 million in IPO – source => Pakistan Army Chief To Visit Saudi Arabia In An Attempt To Wheedle The Latter Over Kashmir Issue
)

)

[query] => https://pubstack.nw18.com/pubsync/v1/api/videos/recommended?source=n18english&channels=5d95e6c378c2f2492e2148a2,5d95e6c278c2f2492e214884,5d96f74de3f5f312274ca307&categories=5d95e6d7340a9e4981b2e10a&publish_min=2020-08-11T07:10:02.000Z&publish_max=2020-08-14T07:10:02.000Z&sort_by=date-relevance&order_by=0&limit=2
)

U.S. retail sales miss expectations in July, may slow further in months ahead

Coronavirus vaccine developer CureVac raises $213 million in IPO – source

CureVac BV raised $213 million in its initial public offering on Thursday, a person familiar with the matter said, setting the stage for the first stock market debut of a company developing a promising vaccine to combat the novel coronavirus.

Speak Your Mind

LEAVE A REPLY Cancel reply

Get in Touch

Recommend for You

Oh hi there It’s nice to meet you.

Subscribe and receive our weekly newsletter packed with awesome articles that really matters to you!

You might also like

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

About Us

Follow Us

Support Us & Be a Patreon

Add QNewsHub to your Homescreen!

Oh hi there
It’s nice to meet you.